Seeking Alpha

Goldman Sachs thinks today's weakness in Intuitive Surgical (ISRG -4.7%) is a buying...

Goldman Sachs thinks today's weakness in Intuitive Surgical (ISRG -4.7%) is a buying opportunity, on the back of what it calls a "solid" Q1 report. Procedure growth may have fallen short of expectations, but Goldman thinks the slowdown looks consistent with trends across the space (seasonality, declines in hospital admissions), and the impact from negative headlines, while unclear and will take time to prove out, are not material.
Comments (6)
  • wow, nothing but cricket's...............
    19 Apr 2013, 01:58 PM Reply Like
  • What does that mean?

     

    Anyway Goldman's note makes sense to me. Also from the top and bottom lines it is obvious the hospital administrators are still buying the device and the doctors are still using it.
    19 Apr 2013, 02:13 PM Reply Like
  • The key question is whether ISRG's lawyers put the blame for the adverse "incidents" on the surgeons performing the operations instead of the Da Vinci system. Even if they can, it would not be surprising if systems order growth slows to the high teens over the next two to three quarters.
    19 Apr 2013, 02:20 PM Reply Like
  • They won't blame the system, they'll blame the training of surgeons, which has been a minimal joke. Training costs money and ISRG has been cutting those costs by cutting the training.
    19 Apr 2013, 02:41 PM Reply Like
  • "ISRG has been cutting those costs by cutting the training."

     

    How about some references for that statement? Besides ISRG charges for and makes money on the training so you are not making sense.
    19 Apr 2013, 02:55 PM Reply Like
  • Anybody remember the Dalkon Shield (sp) ?
    19 Apr 2013, 09:38 PM Reply Like
DJIA (DIA) S&P 500 (SPY)